Sumita Bhatta

518 total citations
10 papers, 192 citations indexed

About

Sumita Bhatta is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Sumita Bhatta has authored 10 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in Sumita Bhatta's work include Multiple Myeloma Research and Treatments (4 papers), Bone health and treatments (3 papers) and Virus-based gene therapy research (2 papers). Sumita Bhatta is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Bone health and treatments (3 papers) and Virus-based gene therapy research (2 papers). Sumita Bhatta collaborates with scholars based in United States, Greece and Spain. Sumita Bhatta's co-authors include Noopur Raje, Evangelos Terpos, Adam J. Fein, Rena M. Conti, Christopher Kim, Rohini K. Hernandez, Rafaël Fonseca, Susan Hong, Dezheng Huo and Blasé N. Polite and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Sumita Bhatta

10 papers receiving 192 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumita Bhatta United States	7	100	61	44	41	32	10	192
Marie Kroemer France	9	105 1.1×	6 0.1×	61 1.4×	14 0.3×	10 0.3×	30	255
Sarah C. Reed United States	7	68 0.7×	15 0.2×	80 1.8×	13 0.3×	2 0.1×	16	180
Sumimasa Nagai Japan	8	66 0.7×	15 0.2×	42 1.0×	59 1.4×		27	196
Mona Shafey Canada	9	96 1.0×	107 1.8×	13 0.3×	12 0.3×	1 0.0×	36	245
Ju‐Whei Lee United States	8	56 0.6×	48 0.8×	33 0.8×	16 0.4×		26	165
S. Verelst Netherlands	6	218 2.2×	261 4.3×	139 3.2×	16 0.4×	2 0.1×	14	337
Salma A. Al‐Hadad Iraq	9	99 1.0×	32 0.5×	37 0.8×	7 0.2×		26	204
A. Megan Cornelison United States	9	52 0.5×	246 4.0×	92 2.1×	3 0.1×	12 0.4×	16	324
Rajni Agarwal‐Hashmi United States	5	54 0.5×	76 1.2×	16 0.4×	6 0.1×	1 0.0×	11	155
Shawnda Tench United States	7	61 0.6×	92 1.5×	14 0.3×	2 0.0×	3 0.1×	17	150

Countries citing papers authored by Sumita Bhatta

Since Specialization

Citations

This map shows the geographic impact of Sumita Bhatta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumita Bhatta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumita Bhatta more than expected).

Fields of papers citing papers by Sumita Bhatta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumita Bhatta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumita Bhatta. The network helps show where Sumita Bhatta may publish in the future.

Co-authorship network of co-authors of Sumita Bhatta

This figure shows the co-authorship network connecting the top 25 collaborators of Sumita Bhatta. A scholar is included among the top collaborators of Sumita Bhatta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumita Bhatta. Sumita Bhatta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Hecht, J. Randolph, Steven S. Raman, Arlene Chan, et al.. (2023). Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases. ESMO Open. 8(2). 100884–100884. 22 indexed citations

Chesney, Jason, Igor Puzanov, Frances A. Collichio, et al.. (2020). Association between complete response and survival in advanced melanoma treated with talimogene laherparepvec (T-VEC) plus ipilimumab (ipi).. Journal of Clinical Oncology. 38(15_suppl). 10029–10029. 1 indexed citations

Milhem, Mohammed, Kevin J. Harrington, Frances A. Collichio, et al.. (2019). Progression-free survival (PFS) in unresectable melanoma patients (pts) treated with talimogene laherparepvec (T-VEC) versus granulocyte macrophage colony-stimulating factor (GM-CSF) in OPTiM.. Journal of Clinical Oncology. 37(15_suppl). 9524–9524. 3 indexed citations

Kim, Christopher, et al.. (2018). Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data. Journal of bone oncology. 14. 100215–100215. 26 indexed citations

Raje, Noopur, Sumita Bhatta, & Evangelos Terpos. (2018). Role of the RANK/RANKL Pathway in Multiple Myeloma. Clinical Cancer Research. 25(1). 12–20. 51 indexed citations

Bhatta, Sumita, et al.. (2017). Multiple Myeloma Patients and Risk of Skeletal Related Events - Real-World Evidence in US Oncology Clinics. Blood. 130. 2171–2171. 1 indexed citations

Raje, Noopur, G. David Roodman, Wolfgang Willenbacher, et al.. (2017). Impact of denosumab (DMB) compared with zoledronic acid (ZA) on renal function in the treatment of myeloma bone disease.. Journal of Clinical Oncology. 35(15_suppl). 8005–8005. 9 indexed citations

Conti, Rena M., Adam J. Fein, & Sumita Bhatta. (2014). National Trends In Spending On And Use Of Oral Oncologics, First Quarter 2006 Through Third Quarter 2011. Health Affairs. 33(10). 1721–1727. 47 indexed citations

Bhatta, Sumita, Ningqi Hou, Blasé N. Polite, et al.. (2013). Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer. SpringerPlus. 2(1). 356–356. 23 indexed citations

10.

Bhatta, Sumita, Kristen Wroblewski, Laura Sit, et al.. (2013). Effects of Vascular Endothelial Growth Factor Signaling Inhibition on Human Erythropoiesis. The Oncologist. 18(8). 965–970. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact